METLIFE INC

MET NYSE CIK: 0001099219

Company Information

Industry Life Insurance
SIC Code 6311
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 200 PARK AVENUE, NEW YORK, NY, 10166
Mailing Address 200 PARK AVENUE, NEW YORK, NY, 10166
Phone 212-578-5500
Fiscal Year End 1231
EIN 134075851

Financial Overview

FY2024

$687.58B
Total Assets
$657.33B
Total Liabilities
$30.02B
Stockholders' Equity
$20.64B
Cash & Equivalents
$1.82
EPS

Recent SEC Filings

Form Type Date Filed Document
13F-HR Institutional investment holdings February 12, 2026 View on SEC
8-K Current report of material events February 4, 2026 View on SEC
8-K Current report of material events January 9, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment January 7, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC
4 Insider stock transaction report January 6, 2026 View on SEC

Material Events

8-K Acquisition December 30, 2025
High Impact
  • MetLife, through its MetLife Investment Management (MIM) division, completed the acquisition of PineBridge Investments, LLC.
  • This acquisition significantly expands MIM's size, assets under management (AUM), and capabilities in investment management.
View Analysis
8-K Strategy Change December 22, 2025
High Impact
  • MetLife released preliminary Q4 and full-year 2025 financial results and shared plans for 2026, including investment income expectations and capital deployment strategies.
  • The company expects Q4 2025 investment income between $385 million and $435 million (pre-tax) and a 7.7% return on private equity for the full year 2025.
View Analysis

Related Companies

Companies in the same industry (SIC: 6311)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.